Btai class action notice: glancy prongay & murray llp files securities fraud lawsuit against bioxcel therapeutics, inc.

Los angeles--(business wire)--glancy prongay & murray llp (“gpm”), announces that it has filed a class action lawsuit in the united states district court for the district of connecticut, captioned martin v. bioxcel therapeutics, inc., et al., case no. 3:23-cv-00915, on behalf of persons and entities that purchased or otherwise acquired bioxcel therapeutics, inc. (“bioxcel” or the “company”) (nasdaq: btai) securities between december 15, 2021 and june 28, 2023, inclusive (the “class period”).
BTAI Ratings Summary
BTAI Quant Ranking